Salvatore Tafuto
- Oncology top 2%
- Lung Cancer Research Studies 33
- Colorectal Cancer Treatments and Studies 20
- Pancreatic and Hepatic Oncology Research 15
- Cancer Treatment and Pharmacology 10
- Neurology top 5%
- Neuroblastoma Research and Treatments 21
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 40
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Otorhinolaryngology top 10%
-
- Sarcoma Diagnosis and Treatment 10
- Co-authors
- Alessandro OttaianoChiara De DivitiisMonica CapozziFabiana TatangeloClaudia von ArxStefania ScalaAntonio AvalloneRossana Casaretti
- Cited by
- OncologyNeurologyEpidemiology
- Partner nations
- ItalyUnited KingdomSpain
In The Last Decade
Salvatore Tafuto
92 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 1.0k
- Neurology 384
- Epidemiology 553
- Hepatology 118
- Otorhinolaryngology 49
Countries citing papers authored by Salvatore Tafuto
This map shows the geographic impact of Salvatore Tafuto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Tafuto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Tafuto more than expected).
Fields of papers citing papers by Salvatore Tafuto
This network shows the impact of papers produced by Salvatore Tafuto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Tafuto. The network helps show where Salvatore Tafuto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Salvatore Tafuto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 22 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 23 | |
| 15 | 2021 | 27 | |
| 16 | 2021 | 51 | |
| 17 | 2021 | 15 | |
| 18 | 2021 | 6 | |
| 19 | 2021 | 6 | |
| 20 | Interleukin-6: biological features and clinical implications. | 1994 | 6 |
About Salvatore Tafuto
Salvatore Tafuto is a scholar working on Oncology, Neurology and Hepatology, having authored 99 papers that have together received 1.5k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (40 papers), Lung Cancer Research Studies (33 papers), Neuroblastoma Research and Treatments (21 papers), Colorectal Cancer Treatments and Studies (20 papers), Pancreatic and Hepatic Oncology Research (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Cancer Treatment and Pharmacology (10 papers) and Sarcoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Oncology (1.0k citations), Neurology (384 citations) and Epidemiology (553 citations). Salvatore Tafuto has collaborated with scholars based in Italy, United Kingdom and Spain. Frequent co-authors include Alessandro Ottaiano, Chiara De Divitiis, Monica Capozzi, Fabiana Tatangelo, Claudia von Arx, Stefania Scala, Antonio Avallone, Rossana Casaretti, Guglielmo Nasti and Paolo Delrio. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.